3-(2, 4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a …

C Gurrieri, F Piazza, M Gnoato, B Montini… - … of Pharmacology and …, 2010 - ASPET
Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory cytokines.
Because bleomycin (BLM) causes lung injury, which is characterized by an inflammatory …
被引用次数：49 相关文章
[PDF] psu.edu

[PDF][PDF] 3-(2, 4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties …

C Gurrieri, F Piazza, M Gnoato, B Montini… - THE JOURNAL OF …, 2010 - Citeseer
ABSTRACT Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory
cytokines. Because bleomycin (BLM) causes lung injury, which is characterized by an …
[PDF] academia.edu

[PDF][PDF] 3-(2, 4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties …

C Gurrieri, F Piazza, M Gnoato, B Montini… - THE JOURNAL OF …, 2010 - academia.edu
ABSTRACT Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory
cytokines. Because bleomycin (BLM) causes lung injury, which is characterized by an …

3-(2, 4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a …

C Gurrieri, F Piazza, M Gnoato, B Montini… - JOURNAL OF …, 2010 - research.unipd.it
Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory cytokines.
Because bleomycin (BLM) causes lung injury, which is characterized by an inflammatory …
[PDF] researchgate.net

[PDF][PDF] 3-(2, 4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties …

C Gurrieri, F Piazza, M Gnoato, B Montini… - THE JOURNAL OF …, 2010 - researchgate.net
ABSTRACT Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory
cytokines. Because bleomycin (BLM) causes lung injury, which is characterized by an …

3-(2, 4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a …

C Gurrieri, F Piazza, M Gnoato… - The Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory cytokines.
Because bleomycin (BLM) causes lung injury, which is characterized by an inflammatory …

3-(2, 4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a …

C Gurrieri, F Piazza, M Gnoato, B Montini… - The Journal of …, 2009 - europepmc.org
Glycogen synthase kinase (GSK)-3 modulates the production of inflammatory cytokines.
Because bleomycin (BLM) causes lung injury, which is characterized by an inflammatory …

[引用][C] 3-(2, 4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2, 5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties …

C Gurrieri, F Piazza, M Gnoato, B Montini… - … of Pharmacology and …, 2009 - cir.nii.ac.jp
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a
Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model …